Ken Griffin's position in Dexcom is currently worth $292 Million. That's 0.42% of their equity portfolio (19th largest holding). The first Dexcom trade was made in Q2 2013. Since then Ken Griffin bought shares 48 more times and sold shares on 33 occasions. The stake costed the investor $144 Million, netting the investor a gain of 104% so far.